What is Mesh Bio?
Mesh Bio operates at the intersection of healthcare and data science, specializing in clinical decision support analytics and automation. Its flagship offering, the DARA Health Intelligence Platform, is engineered to address the complexities of managing chronic diseases, including cardiovascular conditions. By integrating disparate health data, the platform empowers clinicians to deliver data-driven care, thereby improving patient engagement and clinical outcomes. The company addresses a vital market need, as healthcare systems worldwide struggle with the rising prevalence of metabolic diseases and the inefficiencies inherent in traditional care delivery models.
How much funding has Mesh Bio raised?
Mesh Bio has raised a total of $5.3M across 2 funding rounds:
Angel/Seed
$1.8M
Series A
$3.5M
Angel/Seed (2021): $1.8M with participation from SEED Capital, Tael Partners, CITRINE CAPITAL, and Elev8.vc
Series A (2024): $3.5M led by East Ventures
Key Investors in Mesh Bio
East Ventures
East Ventures is a prominent venture capital firm in Southeast Asia, focusing on supporting visionary founders from Seed to Growth stages with an emphasis on sustainable development and social impact.
SEED Capital
A venture capital firm specializing in early-stage investments, providing the necessary resources for startups to scale their innovative business models.
CITRINE CAPITAL
An investment firm focused on identifying and backing high-growth potential companies, often providing strategic guidance alongside financial support.
What's next for Mesh Bio?
With the recent influx of capital, Mesh Bio is poised to expand the reach of its DARA platform, focusing on deeper market penetration and the refinement of its predictive analytics capabilities. The strategic roadmap likely involves scaling the platform's deployment across diverse healthcare environments to further validate its impact on health outcomes. As the company moves into this next phase of growth, it will likely prioritize partnerships with healthcare providers and institutions to solidify its position as a leader in the digital health ecosystem. The focus remains on driving operational efficiency and clinical excellence through technological innovation.
See full Mesh Bio company page
